Early research (Phase 1)UnknownNCT04258072What this trial is testingVactosertib With Nal-IRI/FL in Metastatic Pancreatic Ductal Adenocarcinoma.Who this might be right forPancreas Cancer Samsung Medical Center 24
Testing effectiveness (Phase 2)Ended earlyNCT05169437What this trial is testingNiraparib in the Treatment of Patients With Advanced PALB2 Mutated TumorsWho this might be right forSolid TumorBreast TumorColon Tumor, Malignant+9 more Tempus AI 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07570914What this trial is testingHepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver MetastasesWho this might be right forColorectal Cancer Liver Metastases (CRLM)Colorectal CancerLiver Metastasis Tianjin Medical University Cancer Institute and Hospital 28
Testing effectiveness (Phase 2)Ended earlyNCT01316263What this trial is testingOlaratumab (IMC-3G3) in Previously Treated Participants With Unresectable and/or Metastatic Gastrointestinal Stromal TumorsWho this might be right forGastrointestinal Stromal Tumor (GIST) Eli Lilly and Company 21
Testing effectiveness (Phase 2)Study completedNCT00030563What this trial is testingSurgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the LiverWho this might be right forColorectal CancerMetastatic Cancer University of Washington
Large-scale testing (Phase 3)Study completedNCT03984214What this trial is testingEfficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic CancerWho this might be right forPancreatic Cancer Non-resectableChemotherapy-induced Nausea and VomitingPancreatic Cancer Metastatic Arbeitsgemeinschaft medikamentoese Tumortherapie 109
Testing effectiveness (Phase 2)Ended earlyNCT05188209What this trial is testingEvaluate the Efficacy and Safety of MRG003 in Patients With Advanced Gastric Cancer.Who this might be right forAdvanced or Metastatic Gastric CancerAdvanced or Metastatic Gastroesophageal Junction Carcinoma Lepu Biopharma Co., Ltd. 6
Not applicableStudy completedNCT01834014What this trial is testingExploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver MetastasesWho this might be right forLiver MetastasisColorectal Cancer EPS Corporation 110
Testing effectiveness (Phase 2)Study completedNCT03427814What this trial is testingStudy of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric CancerWho this might be right forAdvanced or Inoperable Gastric Cancer BeiGene 136
Testing effectiveness (Phase 2)UnknownNCT04970914What this trial is testingAnlotinib Plus Penpulimab (AK105) for Chemo-refractory Metastatic Colorectal Cancer:ALTER-C003Who this might be right forColorectal Cancer Peking Union Medical College Hospital 32
Large-scale testing (Phase 3)Active Not RecruitingNCT04230187What this trial is testingBevacizumab Plus mFOLFOXIRI as First-line Treatment for Patients With Unresectable Metastatic Colorectal CancerWho this might be right forColorectal Cancer Yanhong Deng 528
Testing effectiveness (Phase 2)Study completedNCT02080221What this trial is testingBrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group TrialWho this might be right forMetastatic Pancreatic Cancer Brown University 50
Testing effectiveness (Phase 2)Study completedNCT00125021What this trial is testingTarceva and Capecitabine for Pancreatic CancerWho this might be right forPancreatic CancerNeoplasm Metastasis Dana-Farber Cancer Institute 32
Testing effectiveness (Phase 2)Looking for participantsNCT07189871What this trial is testing177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsWho this might be right forCastration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more Radiopharm Theranostics, Ltd 61
Early research (Phase 1)Ended earlyNCT06194877What this trial is testingInvestigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal CancersWho this might be right forColorectal CancerPancreatic Ductal CancerAdvanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers MapKure, LLC 13
Large-scale testing (Phase 3)Study completedNCT00471146What this trial is testingStudy Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.Who this might be right forCarcinoma, Pancreatic Ductal Pfizer 630
Testing effectiveness (Phase 2)UnknownNCT03927495What this trial is testingKN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma Shanghai Chest Hospital 100
Early research (Phase 1)UnknownNCT05213195What this trial is testingNKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal CancerWho this might be right forRefractory Metastatic Colorectal Cancer Zhejiang University 38
Early research (Phase 1)Study completedNCT00039403What this trial is testingUCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic CancerWho this might be right forAdenocarcinoma of the PancreasRecurrent Pancreatic CancerStage II Pancreatic Cancer+2 more National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT01835041What this trial is testingCPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic CancerWho this might be right forAcinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+1 more Wake Forest University Health Sciences 21